Increased coronary vessel wall thickness in HIV-infected young adults

Clinical Infectious Diseases

Volumn 59, Issue 12, 2014, Pages 1779-1786

  Abd Elmoniem, Khaled Z ^a   Unsal, Aylin B ^b   Eshera, Sarah ^a   Matta, Jatin R ^a   Muldoon, Nancy ^c   McAreavey, Dorothea ^c   Purdy, Julia B ^c   Hazra, Rohan ^d   Hadigan, Colleen ^b   Gharib, Ahmed M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Clinical Center   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

antiretroviral therapy; cardiovascular disease; coronary artery; perinatal HIV; smoking

Indexed keywords

FAT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STAVUDINE;

ADOLESCENT; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY PLAQUE; CORONARY VESSEL WALL THICKNESS; CROSS-SECTIONAL STUDY; DRUG EXPOSURE; EPICARDIUM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIGHT CORONARY ARTERY; SMOKING; TIME RESOLVED PHASE SENSITIVE DUAL INVERSION RECOVERY BLACK BLOOD VESSEL WALL MAGNETIC RESONANCE IMAGING; TREATMENT DURATION; YOUNG ADULT; PATHOLOGY; RADIOGRAPHY;

ADOLESCENT; ADULT; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84925018044     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu672     Document Type: Article

References (35)

1. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8:e81355.
2. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, aging, and non-AIDS related morbidity. BMJ 2009; 338:a3172.
3. Sainz T, Alvarez-Fuente M, Navarro ML, et al. Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the CaroVIH Study. J Acquir Immune Defic Syndr 2014; 65:42-9.
4. Duarte H, Matta JR, Muldoon N, Masur H, Hadigan C, Gharib AM. Non-calcified coronary plaque volume inversely related to CD4(+) T-cell count in HIV infection. Antivir Ther 2012; 17:763-7.
5. Lo J, Abbara S, Shturman L, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2010; 24:243-53.
6. Abd-Elmoniem KZ, Gharib AM, Pettigrew RI. Coronary vessel wall 3-T MR imaging with time-resolved acquisition of phase-sensitive dual inversion-recovery (TRAPD) technique: initial results in patients with risk factors for coronary artery disease. Radiology 2012; 265:715-23.
7. Gharib AM, Zahiri H, Matta J, Pettigrew RI, Abd-Elmoniem KZ. Feasibility of coronary artery wall thickening assessment in asymptomatic coronary artery disease using phase-sensitive dual-inversion recovery MRI at 3T. Mag Res Imaging 2013; 31:1051-8.
8. Gharib AM, Pettigrew RI, Elagha A, et al. Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography. Am J Roentgenol 2009; 193:W478-81.
9. Rybicki FJ, Otero HJ, Steigner ML, et al. Initial evaluation of coronary images from 320-detector row computed tomography. Int J Cardiovasc Imaging 2008; 24:535-46.
10. Min JK, Feignoux J, Treutenaere J, Laperche T, Sablayrolles J. The prognostic value of multidetector coronary CT angiography for the prediction of major adverse cardiovascular events: a multicenter observational cohort study. Int J Cardiovasc Imaging 2010; 26:721-8.
11. Min JK, Shaw LJ, Devereux RB, et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of allcause mortality. J Am Coll Cardiol 2007; 50:1161-70.
12. Mikhail IJ, Purdy JB, Dimock DS, et al. High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life. Pediatr Infect Dis J 2011; 30:710-2.
13. Yerramasu A, Dey D, Venuraju S, et al. Increased volume of epicardial fat is an independent risk factor for accelerated progression of subclinical coronary atherosclerosis. Atherosclerosis 2012; 220:223-30.
14. Botnar RM, Stuber M, Kissinger KV, Kim WY, Spuentrup E, Manning WJ. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000; 102:2582-7.
15. Stuber M, Botnar RM, Danias PG, et al. Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography. J Am Coll Cardiol 1999; 34:524-31.
16. Abd-Elmoniem KZ, Weiss RG, Stuber M. Phase-sensitive black-blood coronary vessel wall imaging. Magn Reson Med 2010; 63:1021-30.
17. Meyer CH, Pauly JM, Macovski A, Nishimura DG. Simultaneous spatial and spectral selective excitation. Magn Reson Med 1990; 15:287-304.
18. Fischer SE, Wickline SA, Lorenz CH. Novel real-time R-wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance acquisitions. Magn Reson Med 1999; 42:361-70.
19. Bachar GN, Dicker D, Kornowski R, Atar E. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol 2012; 110:534-8.
20. Miao C, Chen S, Macedo R, et al. Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009; 53:1708-15.
21. Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis 2011; 214:468-73.
22. Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA 2012; 308:379-86.
23. Vigano A, Bedogni G, Cerini C, et al. Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults. Curr HIV Res 2010; 8:411-7.
24. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 43:1731-7.
25. Perlstein TS, Lee RT. Smoking, metalloproteinases, and vascular disease. Arterioscler Thromb Vasc Biol 2006; 26:250-6.
26. Desvarieux M, Boccara F, Meynard JL, et al. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIVinfected never-smokers independent of antiretroviral therapy. AIDS 2013; 27:2603-14.
27. Di Biagio A, Rosso R, Maggi P, et al. Inflammation markers correlate with common carotid intima-media thickness in patients perinatally infected with human immunodeficiency virus 1. J Ultrasound Med 2013; 32:763-8.
28. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109:1603-8.
29. Charakida M, Donald AE, Green H, et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 2005; 112:103-9.
30. Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis 2006; 185:1-11.
31. Friis-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-35.
32. McComsey GA, O'Riordan M, Hazen SL, et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 2007; 21:921-7.
33. Velsor LW, Kovacevic M, Goldstein M, Leitner HM, Lewis W, Day BJ. Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine. Toxicol Appl Pharmacol 2004; 199:10-9.
34. Xue SY, Hebert VY, Hayes DM, Robinson CN, Glover M, Dugas TR. Nucleoside reverse transcriptase inhibitors induce a mitophagyassociated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment. Toxicol Sci 2013; 134:323-34.
35. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003; 42:1075-81.